Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-04

FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA supplemental approval for oxybutynin chloride submitted by Chartwell RX, LLC for an existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)